Clinical Trials List
Protocol NumberC-07-63
2008-11-01 - 2010-06-30
Phase III
Terminated3
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 戴明正 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 程景煜 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
800 participants
